These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 26982182)

  • 41. miR-324-5p upregulation potentiates resistance to cisplatin by targeting FBXO11 signalling in non-small cell lung cancer cells.
    Ba Z; Zhou Y; Yang Z; Xu J; Zhang X
    J Biochem; 2019 Dec; 166(6):517-527. PubMed ID: 31778188
    [TBL] [Abstract][Full Text] [Related]  

  • 42. EGCG inhibits CSC-like properties through targeting miR-485/CD44 axis in A549-cisplatin resistant cells.
    Jiang P; Xu C; Chen L; Chen A; Wu X; Zhou M; Haq IU; Mariyam Z; Feng Q
    Mol Carcinog; 2018 Dec; 57(12):1835-1844. PubMed ID: 30182373
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Silencing of periostin inhibits nicotine-mediated tumor cell growth and epithelial-mesenchymal transition in lung cancer cells.
    Wu SQ; Lv YE; Lin BH; Luo LM; Lv SL; Bi AH; Jia YS
    Mol Med Rep; 2013 Mar; 7(3):875-80. PubMed ID: 23314871
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Downregulation of Meg3 enhances cisplatin resistance of lung cancer cells through activation of the WNT/β-catenin signaling pathway.
    Xia Y; He Z; Liu B; Wang P; Chen Y
    Mol Med Rep; 2015 Sep; 12(3):4530-4537. PubMed ID: 26059239
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Par-4 downregulation confers cisplatin resistance in pancreatic cancer cells via PI3K/Akt pathway-dependent EMT.
    Tan J; You Y; Xu T; Yu P; Wu D; Deng H; Zhang Y; Bie P
    Toxicol Lett; 2014 Jan; 224(1):7-15. PubMed ID: 24144893
    [TBL] [Abstract][Full Text] [Related]  

  • 46. IL-6 signaling contributes to cisplatin resistance in non-small cell lung cancer via the up-regulation of anti-apoptotic and DNA repair associated molecules.
    Duan S; Tsai Y; Keng P; Chen Y; Lee SO; Chen Y
    Oncotarget; 2015 Sep; 6(29):27651-60. PubMed ID: 26313152
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cisplatin resistance in non-small cell lung cancer cells is associated with an abrogation of cisplatin-induced G2/M cell cycle arrest.
    Sarin N; Engel F; Kalayda GV; Mannewitz M; Cinatl J; Rothweiler F; Michaelis M; Saafan H; Ritter CA; Jaehde U; Frötschl R
    PLoS One; 2017; 12(7):e0181081. PubMed ID: 28746345
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Insulin-like growth factor-I receptor signaling pathway induces resistance to the apoptotic activities of SCH66336 (lonafarnib) through Akt/mammalian target of rapamycin-mediated increases in survivin expression.
    Oh SH; Jin Q; Kim ES; Khuri FR; Lee HY
    Clin Cancer Res; 2008 Mar; 14(5):1581-9. PubMed ID: 18316583
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inactivation of AKT/NF‑κB signaling by eurycomalactone decreases human NSCLC cell viability and improves the chemosensitivity to cisplatin.
    Dukaew N; Chairatvit K; Pitchakarn P; Imsumran A; Karinchai J; Tuntiwechapikul W; Wongnoppavich A
    Oncol Rep; 2020 Oct; 44(4):1441-1454. PubMed ID: 32945500
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Activation of ERK1/2 and Akt is associated with cisplatin resistance in human lung cancer cells.
    Wang M; Liu ZM; Li XC; Yao YT; Yin ZX
    J Chemother; 2013 Jun; 25(3):162-9. PubMed ID: 23783141
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Experimental study of antisense oligodeoxynucleotide targeting survivin gene for cisplatin resistant human lung adeno-carcinoma xenograft in nude mice].
    Zhang MC; Hu CP; Chen Q; Xia Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 31(5):717-22. PubMed ID: 17062938
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Upregulation of CXCR4 is functionally crucial for maintenance of stemness in drug-resistant non-small cell lung cancer cells.
    Jung MJ; Rho JK; Kim YM; Jung JE; Jin YB; Ko YG; Lee JS; Lee SJ; Lee JC; Park MJ
    Oncogene; 2013 Jan; 32(2):209-21. PubMed ID: 22370645
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enhancement of cisplatin sensitivity in lung cancer xenografts by liposome-mediated delivery of the plasmid expressing small hairpin RNA targeting Survivin.
    Tian H; Liu S; Zhang J; Zhang S; Cheng L; Li C; Zhang X; Dail L; Fan P; Dai L; Yan N; Wang R; Wei Y; Deng H
    J Biomed Nanotechnol; 2012 Aug; 8(4):633-41. PubMed ID: 22852473
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ABT-737 Synergizes with Cisplatin Bypassing Aberration of Apoptotic Pathway in Non-small Cell Lung Cancer.
    Kim EY; Jung JY; Kim A; Chang YS; Kim SK
    Neoplasia; 2017 Apr; 19(4):354-363. PubMed ID: 28319809
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Baicalein increases cisplatin sensitivity of A549 lung adenocarcinoma cells via PI3K/Akt/NF-κB pathway.
    Yu M; Qi B; Xiaoxiang W; Xu J; Liu X
    Biomed Pharmacother; 2017 Jun; 90():677-685. PubMed ID: 28415048
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cancer-associated fibroblasts treated with cisplatin facilitates chemoresistance of lung adenocarcinoma through IL-11/IL-11R/STAT3 signaling pathway.
    Tao L; Huang G; Wang R; Pan Y; He Z; Chu X; Song H; Chen L
    Sci Rep; 2016 Dec; 6():38408. PubMed ID: 27922075
    [TBL] [Abstract][Full Text] [Related]  

  • 57. miR-202 Enhances the Anti-Tumor Effect of Cisplatin on Non-Small Cell Lung Cancer by Targeting the Ras/MAPK Pathway.
    Sun W; Ping W; Tian Y; Zou W; Liu J; Zu Y
    Cell Physiol Biochem; 2018; 51(5):2160-2171. PubMed ID: 30522099
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Upregulated expression of periostin by hypoxia in non-small-cell lung cancer cells promotes cell survival via the Akt/PKB pathway.
    Ouyang G; Liu M; Ruan K; Song G; Mao Y; Bao S
    Cancer Lett; 2009 Aug; 281(2):213-9. PubMed ID: 19328625
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synergistic Induction of Erlotinib-Mediated Apoptosis by Resveratrol in Human Non-Small-Cell Lung Cancer Cells by Down-Regulating Survivin and Up-Regulating PUMA.
    Nie P; Hu W; Zhang T; Yang Y; Hou B; Zou Z
    Cell Physiol Biochem; 2015; 35(6):2255-71. PubMed ID: 25895606
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cx43 reverses the resistance of A549 lung adenocarcinoma cells to cisplatin by inhibiting EMT.
    Yu M; Zhang C; Li L; Dong S; Zhang N; Tong X
    Oncol Rep; 2014 Jun; 31(6):2751-8. PubMed ID: 24789679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.